CTOR
CITIUS ONCOLOGY, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$0.54
−6.40%Forward multiples
Based on analyst estimates
- P/E forward
- 2.70x
- P/E 2026E
- —
- P/E 2027E
- 5.11x
- P/E 2028E
- 1.11x
- P/S forward
- 0.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.24x
- Price / sales
- 7.07x
- Price / cash flow
- -2.55x
Enterprise value
- Enterprise value
- $43.8M
- EV / sales
- 6.17x
- EV / EBITDA
- -1.02x
- EV / EBIT
- -0.93x
- Market cap
- $50.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026